Genetic predictive factors in restenosis

Pathologie Biologie

Volumn 52, Issue 4, 2004, Pages 186-195

  Monraats, P S ^a   Agema, W R P ^a,b   Jukema, J W ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Ballon; Balloon; Genetics; G n tique; Percutaneous transluminal coronary angioplasty (PTCA); Polymorphisme; Polymorphisms; PTCA; Restenosis; Rest nose; Stent

Indexed keywords

HEPARIN; LIPID; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PRAVASTATIN;

ARTERY INTIMA PROLIFERATION; CELL PROLIFERATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY STENT; DNA MICROARRAY; ERROR; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; META ANALYSIS; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTENOSIS; REVIEW; RISK; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 2442503680     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.02.003     Document Type: Article

References (51)

1. Fattori R., Piva T. Drug-eluting stents in vascular intervention. Lancet. 361:(9353):2003;247-249
2. Pache J., Kastrati A., Mehilli J., Schuhlen H., Dotzer F., Hausleiter J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 41:(8):2003;1283-1288
3. Koch W., Schomig A., Kastrati A. Genetic risk factors and restenosis after coronary artery stenting. Cardiol Int. 4:(1):2003;10-17
4. Bhargava B., Karthikeyan G., Abizaid A.S., Mehran R. New approaches to preventing restenosis. Br Med J. 327:(7409):2003;274-279
5. Mehilli J., Kastrati A., Bollwein H., Dibra A., Schuhlen H., Dirschinger J., et al. Gender and restenosis after coronary artery stenting. Eur Heart J. 24:(16):2003;1523-1530
6. Agema W.R., Jukema J.W., Pimstone S.N., Kastelein J.J. Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy. Eur Heart J. 22:(22):2001;2058-2074
7. Mercado N., Boersma E., Wijns W., Gersh B.J., Morillo C.A., de V., et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol. 38:(3):2001;645-652
8. Cutlip D.E., Chauhan M.S., Baim D.S., Ho K.K., Popma J.J., Carrozza J.P., et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 40:(12):2002;2082-2089
9. Weintraub W.S., Kosinski A.S., Brown C.L. III, King S.B. III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 21:(1):1993;6-14
10. Kastrati A., Dirschinger J., Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz. 25:(1):2000;34-46
11. Bauters C., Hubert E., Prat A., Bougrimi K., Van Belle E., McFadden E.P., et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 31:(6):1998;1291-1298
12. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban H.E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New Engl J Med. 346:(23):2002;1773-1780
13. Agema W.R., Jukema J.W., Zwinderman A.H., van der Wall E.E. A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J. 144:(5):2002;760-768
14. Ohishi M., Fujii K., Minamino T., Higaki J., Kamitani A., Rakugi H., et al. A potent genetic risk factor for restenosis. Nat Genet. 5:(4):1993;324-325
15. Gensini F., Battaglini B., Fatini C., Guazzelli R., Falai M., Chioccioli M., et al. I/D polymorphism of the ACE gene and A1166C of the AT1R gene as risk factors for restenosis after coronary angioplasty. Minerva Cardioangiol. 47:(12):1999;516
16. Volzke H., Hertwig S., Rettig R., Motz W. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty. Clin Sci (Lond). 99:(1):2000;19-25
17. Samani N.J., Martin D.S., Brack M., Cullen J., Chauhan A., Lodwick D., et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet. 345:(8956):1995;1013- 1016
18. Koch W., Kastrati A., Mehilli J., Bottiger C., von Beckerath N., Schomig A. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation. 102:(2):2000;197-202
19. Ribichini F., Steffenino G., Dellavalle A., Matullo G., Colajanni E., Camilla T., et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 97:(2):1998;147-154
20. Hamon M., Fradin S., Denizet A., Filippi-Codaccioni E., Grollier G., Morello R. Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention. Heart. 89:(3):2003;321-325
21. Bonnici F., Keavney B., Collins R., Danesh J. Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. Br Med J. 325:(7363):2002;517-520
22. Kastrati A., Schomig A., Seyfarth M., Koch W., Elezi S., Bottiger C., et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation. 99:(8):1999;1005-1010
23. Wheeler G.L., Braden G.A., Bray P.F., Marciniak S.J., Mascelli M.A., Sane D.C. Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. Am Heart J. 143:(1):2002;76-82
24. Mamotte C.D., van Bockxmeer F.M., Taylor R.R. PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol. 82:(1):1998;13-16
25. Bottiger C., Kastrati A., Koch W., Mehilli J., von Beckerath N., Dirschinger J., et al. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. Am J Cardiol. 84:(9):1999;987-991
26. von Beckerath N., Koch W., Mehilli J., Bottiger C., Braun S., Schomig A., et al. Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. Atherosclerosis. 156:(2):2001;463-468
27. Kastrati A., Koch W., Berger P.B., Mehilli J., Stephenson K., Neumann F.J., et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol. 36:(7):2000;2168-2173
28. Francis S.E., Camp N.J., Burton A.J., Dewberry R.M., Gunn J., Stephens-Lloyd A., et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart. 86:(3):2001;336-340
29. Marculescu R., Mlekusch W., Exner M., Sabeti S., Michor S., Rumpold H., et al. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty. Thromb Haemost. 90:(3):2003;491-500
30. Gomma A.H., Elrayess M.A., Knight C.J., Hawe E., Fox K.M., Humphries S.E. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 23:(24):2002;1955-1962
31. Rauchhaus M., Gross M., Schulz S., Francis D.P., Greiser P., Norwig A., et al. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int J Cardiol. 83:(3):2002;249-257
32. Koch W., Bottiger C., Mehilli J., von Beckerath N., Neumann F.J., Schomig A., et al. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting. Am J Cardiol. 88:(10):2001;1120-1124
33. Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 99:(25):1999;3218-3220
34. Zee R.Y., Hoh J., Cheng S., Reynolds R., Grow M.A., Silbergleit A., et al. Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenom J. 2:(3):2002;197-201
35. Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner G., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 107:(12):2003;1579-1585
36. Humphries S., Bauters C., Meirhaeghe A., Luong L., Bertrand M., Amouyel P. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J. 23:(9):2002;721-725
37. de Maat M.P., Jukema J.W., Ye S., Zwinderman A.H., Moghaddam P.H., Beekman M., et al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol. 83:(6):1999;852-856
38. Pesonen U., Koch W., Schomig A., Kastrati A. Leucine 7 to proline 7 polymorphism of the preproneuropeptide y gene is not associated with restenosis after coronary stenting. J Endovasc Ther. 10:(3):2003;566-572
39. von Beckerath N., Kastrati A., Koch W., Bottiger C., Mehilli J., Seyfarth M., et al. G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis. 149:(1):2000;151-155
40. Samani N.J., Martin D.S., Brack M., Cullen J., Wallis R., Lodwick D., et al. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty. Atherosclerosis. 125:(2):1996;209-216
41. van Bockxmeer F.M., Mamotte C.D., Gibbons F.R., Taylor R.R. Apolipoprotein epsilon 4 homozygosity - a determinant of restenosis after coronary angioplasty. Atherosclerosis. 110:(2):1994;195-202
42. Flork L., Jouanel P., Lusson J.R., Leaute S., Dauphin C., Motreff P., et al. Influence of alleles of apolipoprotein E on restenosis after coronary angioplasty in women. Arch Mal Coeur Vaiss. 91:(12):1998;1475-1479
43. Tada H. The E4 allele of apolipoprotein E is associated with increased restenosis after coronary angioplasty. Tokai J Exp Clin Med. 26:(3):2001;81-92
44. Ribichini F., Wijns W., Ferrero V., Matullo G., Camilla T., Feola M., et al. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am J Cardiol. 91:(2):2003;154-158
45. Wehinger A., Kastrati A., Elezi S., Baum H., Braun S., Neumann F.J., et al. Lipoprotein(a) and coronary thrombosis and restenosis after stent placement. J Am Coll Cardiol. 33:(4):1999;1005-1012
46. Gazzaruso C., Garzaniti A., Falcone C., Geroldi D., Turpini C., Fratino P. Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? Int J Cardiol. 87:(1):2003;91-98
47. Roguin A., Ribichini F., Ferrero V., Matullo G., Herer P., Wijns W., et al. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. Am J Cardiol. 89:(7):2002;806-810
48. Gorchakova O., Koch W., von Beckerath N., Mehilli J., Schomig A., Kastrati A. Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement. Eur Heart J. 24:(9):2003;820-827
49. Suzuki T., Okumura K., Sone T., Kosokabe T., Tsuboi H., Kondo J., et al. The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis. Int J Cardiol. 86:(1):2002;71-76
50. Volzke H., Grimm R., Robinson D.M., Wolff B., Schwahn C., Hertwig S., et al. Candidate genetic markers and the risk of restenosis after coronary angioplasties. Clin Sci (Lond). 2003
51. Hedman M., Hartikainen J., Syvanne M., Stjernvall J., Hedman A., Kivela A., et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 107:(21):2003;2677-2683